文献速递真菌感染

曲霉与宿主-病原体相互作用:聚焦治疗相关方面

Aspergillus and host-pathogen interaction: focus on treatment-relevant aspects.
PubMed 文献 · Clin Microbiol Infect · 2025-09-03

本综述分析曲霉与宿主免疫相互作用的多样角色,整合临床前模型与临床研究,评估免疫靶向治疗作为传统抗真菌治疗辅助手段的潜力。强调基于个体免疫特征的个性化治疗策略,并指出知识空白与未来研究方向。

要点

  • 侵袭性曲霉病治疗结局欠佳,抗真菌耐药上升,需借助宿主免疫机制的辅助治疗。
  • 宿主防御涉及固有与适应性、细胞与体液免疫的复杂互作,且异质性强。
  • 靶向免疫治疗仍处早期,但为侵袭性曲霉病管理提供新兴有前景的方向。

核心结论

  • 深入理解侵袭性曲霉病中的宿主免疫可为更精准、有效和个性化的治疗策略铺路,有望显著改善脆弱患者结局。

研究设计与样本

  • 综述,通过全面分析近期相关同行评议文献,综合曲霉-宿主相互作用及新兴治疗策略。

主要发现

  • 侵袭性曲霉病仍是免疫受损个体发病和死亡的主要原因,高危人群谱在扩大,尤其在重症监护环境。
  • 宿主防御涉及固有与适应性、细胞与体液免疫成分的复杂互作,但该反应复杂且异质,挑战统一治疗方法的有效性。
  • 免疫靶向治疗作为传统抗真菌治疗的辅助手段,在临床前模型与临床研究中显示出潜力,强调个性化方法的前景。

临床怎么用

  • 在传统抗真菌治疗基础上,可关注基于个体免疫特征的免疫靶向辅助治疗策略。
  • 对免疫受损患者,尤其重症监护环境中的高危人群,应重视宿主免疫状态对治疗的影响。

局限性

  • 靶向免疫治疗仍处于早期阶段。
  • 存在现有知识空白,需未来研究与临床应用进一步明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Invasive aspergillosis (IA) remains a major cause of morbidity and mortality in immunocompromised individuals, with an expanding spectrum of at-risk populations, particularly in intensive care settings. Despite advances in antifungal pharmacotherapy, treatment outcomes remain suboptimal, and the rise of antifungal resistance highlights the need for adjunctive therapy that leverages host immune mechanisms. The pathogenesis of IA is primarily driven by impaired or dysregulated immune responses to Aspergillus species, mainly Aspergillus fumigatus. Host defence involves a complex interplay of innate and adaptive, cellular and humoral immune components. However, this response is not only intricate but also heterogenous, challenging the effectiveness of uniform treatment approaches. OBJECTIVES: This review aims to examine the diverse roles of immune components in host-Aspergillus interactions and to explore how these insights are currently informing the development of novel immune-targeted therapies. SOURCES: A thorough analysis of recent and relevant peer-reviewed literature was conducted to synthesize current understanding of Aspergillus-host interactions and the emerging therapeutic strategies derived from these insights. CONTENT: Following a brief overview of the immunopathogenesis of IA, we integrate findings from both preclinical models and clinical studies to evaluate the potential of immune-based therapies as adjuncts to traditional antifungal treatment. Emphasis is placed on the promise of personalized approaches tailored to individual immune profiles. We also address existing knowledge gaps and outline key directions for future research and clinical application. IMPLICATIONS: A deeper understanding of host immunity in IA paves the way for more precise, effective, and personalized therapeutic strategies, with the potential to significantly improve outcomes in vulnerable patient populations. Although still in its early stages, targeted immunotherapy represents an emerging and promising perspective in infectious diseases management. Insights gained from IA may also inform the development of immune-based interventions for other opportunistic infections.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Manchon R, Feys S, Hoenigl M, et al. Aspergillus and host-pathogen interaction: focus on treatment-relevant aspects. Clin Microbiol Infect. 2025. PMID: 40912458. doi:10.1016/j.cmi.2025.08.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。